New State-of-the-Art
Research Program

Established in 2004, the Gynecologic Disease Program is a collaborative research partnership involving Walter Reed Army Medical Center, the University of Pittsburgh Cancer Institute, the Windber Research Institute, and Georgetown University Medical Center. Funding management is provided by the Telemedicine and Advanced Technology Research Center of the United States Army Medical Research and Materiel Command.

The primary objective of the Gynecologic Disease Program is to develop state-of-the-art capabilities in clinical and basic science research aimed at improving screening, early detection, prevention, and treatment of gynecologic disease for military health beneficiaries. Using microarrays, proteomics analysis, and other laboratory technologies, the group will identify molecular alterations associated with different gynecologic cancers and use this information with epidemiologic data to develop novel chemopreventive and therapeutic strategies. We are also developing new technologies in imaging, image-guided robotics, gene therapy, and minimally-invasive interventional radiology. These innovations will be clinically evaluated in patients with benign and malignant gynecologic tumors. With information gained from these research activities, we will continue to improve screening, early detection, prevention, and treatment of gynecologic disease.